This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on:

DISCOVERY, DEVELOPMENT & BIOANALYTICAL STRATEGIES TOWARDS NEXT GENERATION ADC:

• Better understandable, more precise and new targets

• Alternative scaffolds and new payloads

• Optimized conjugation chemistry and stability

• Improved therapeutic index

SUCCESSFUL TRANSLATION INTO CLINIC & CLINICAL PROGRESS:

•ADC to treat tumors of the hematopoietic and lymphoid tissues

•ADC to treat solid tumors

•ADC to treat non-oncology diseases

•ADC - immuno-oncology combinations

• Bispecific